Private Equity Quietly Reshapes India’s Hospital Landscape, Landmark Study Reveals

Private equity has become one of the most powerful and least visible forces in Indian health care, and until now nobody had systematically mapped its footprint. A new study published in BMC Health Services Research by Megha Reddy and Yashaswini Singh of Brown University School of Public Health and Cyrus Engineer of the Johns Hopkins Bloomberg School of Public Health offers the first comprehensive accounting of private equity ownership across India’s sprawling health care sector. Drawing on transaction-level data from the financial database PitchBook and painstaking manual verification against news reports, press releases, and provider websites, the researchers identified seventy private equity-backed acquisitions in India between January 2007 and May 2025. The picture that emerges is striking: a wave of foreign-financed capital that accelerated dramatically after 2020, concentrated overwhelmingly in multispecialty hospitals in the urbanized south of the country, while vast rural and underserved regions attracted little or no investment at all.

The mechanics of private equity in health care are worth understanding, because they explain both the appeal and the anxiety surrounding this form of investment. Private equity firms pool capital from institutional investors and use it, often combined with substantial borrowed funds, to acquire companies outright through leveraged buyouts. The goal is to restructure the acquired business, streamline operations, expand revenue, and sell it again within a relatively short investment horizon, typically five to seven years, at a substantial profit. In health care, that model has raised persistent concerns in the countries where it has been studied most intensively, particularly the United States. There, a growing body of empirical research has linked private equity ownership of hospitals and physician practices to higher prices, reductions in clinical staffing, and mixed or contested effects on the quality of patient care. Critics point to provider consolidation, facility closures, and diminished workforce autonomy as recurring themes in the American experience.

What has been missing, the authors argue, is any comparable evidence base for India, despite the country’s rapid emergence as one of the world’s most attractive destinations for health care investment. Favorable policy reforms, supportive macroeconomic conditions, and rising demand for medical services from a growing middle class have combined to make Indian health care an increasingly tempting target for global capital. Yet the scale, ownership patterns, and geographic distribution of that capital had never been systematically documented. The new study fills that gap by focusing on leveraged buyout transactions across four segments of the sector: clinics and outpatient services, elder and disabled care, hospital and inpatient services, and laboratory services. Each entry in the dataset was manually verified using public sources to guard against the errors and omissions that plague purely automated financial databases.

The headline finding is that hospitals, and particularly multispecialty hospital chains, accounted for nearly two-thirds of all private equity investments identified in the study. This concentration matters because hospitals sit at the apex of any health system, commanding the largest budgets, the most specialized workforce, and the greatest capacity to influence patterns of care downstream. When investors target multispecialty chains rather than single facilities, they are effectively buying platforms that can be expanded through further acquisitions, a strategy known in the industry as platform consolidation. The study’s descriptive statistics on deal volume over time show that most of the seventy acquisitions occurred after 2020, suggesting that the post-pandemic period marked an inflection point at which global investors, flush with capital and drawn by India’s growth trajectory, moved decisively into the sector.

Geography tells an equally consequential story. The study found pronounced clustering of private equity acquisitions in southern, urbanized states such as Karnataka, Maharashtra, and Telangana, home to major metropolitan hubs like Bengaluru, Mumbai, and Hyderabad. These states already possess relatively dense private health care infrastructure, established hospital chains, and affluent patient populations capable of paying for premium services. By contrast, rural and underserved regions of India saw limited to no private equity investment whatsoever. This pattern underscores a structural tension at the heart of the private equity model: capital flows toward markets where returns are most reliable, which in health care means urban populations with purchasing power, not the hundreds of millions of Indians who live in areas with chronic shortages of doctors, beds, and diagnostic facilities. The investment wave, in other words, is widening rather than narrowing existing disparities in access.

Perhaps the most eye-opening statistic in the study concerns the origin of the money. Nearly sixty-seven percent of all private equity acquisitions in the study sample were financed solely by foreign private equity firms. That figure positions India firmly as an emerging market darling for international health care investors and raises distinctive policy questions that differ from those confronted in the United States, where most investors are domestic. Foreign ownership introduces additional layers of complexity for regulators, including questions about capital repatriation, cross-border governance of health care assets, and the degree to which investment decisions affecting Indian patients are made in boardrooms far from the facilities themselves. The authors note that this foreign dominance underscores India’s attractiveness as an investment destination, but it also means that the regulatory frameworks India builds will need to account for actors whose fiduciary duties run to global limited partners rather than local communities.

The study also examined exit activity, including secondary sales and initial public offerings, which mark the moments when private equity firms realize their returns. Tracking exits is essential to understanding the full life cycle of private equity ownership, because the pressure to exit profitably within a defined window shapes the operational decisions firms make while they own a facility or chain. Although the study’s abstract does not detail the full distribution of exits, its inclusion of secondary sales and IPOs in the analytical framework signals a maturing market in which acquired assets are already being traded onward, sometimes to subsequent investors and sometimes to public markets. Each handoff raises the question of what happens to pricing, staffing, and care standards across successive owners with short-term mandates.

For policymakers in India, the study arrives at a critical moment. The authors are careful to note that the larger effects of private equity investment on health care delivery and pricing in India remain unknown; the seventy acquisitions they document establish a baseline, not a verdict. But the American literature offers a cautionary preview of the mechanisms worth monitoring: leveraged transactions can load acquired hospitals with debt, debt service can squeeze operating budgets, and squeezed budgets can translate into staffing cuts or price increases. The researchers argue that India should begin strengthening disclosure requirements so that the public can see who owns which facilities, and should systematically monitor outcomes following private equity acquisition, including impacts on costs, patient care, and workforce dynamics. At the same time, they acknowledge the other side of the ledger: private equity can supply critical capital for growth in a health system that remains fragmented and underfunded, and its capacity to bring scale and professional management to the sector is a genuine potential benefit.

The authors are candid about the limits of their vantage point. In a reflexivity statement, they acknowledge that all three are based at United States institutions and approached the study as external observers rather than researchers embedded within the Indian health system. They recognize that this distance may have limited their ability to identify locally salient dynamics, such as regional regulatory variation or the perspectives of Indian providers, that India-based scholars might have surfaced. They describe the work as a starting point for further inquiry, ideally conducted in collaboration with Indian researchers and stakeholders, and they ground their analysis in India-specific policy and market context to mitigate the limitations of their positionality. That transparency is a model for global health research that increasingly crosses borders of both geography and capital.

What makes this study resonate far beyond health policy circles is the speed and silence of the transformation it documents. Seventy acquisitions in under two decades, most of them clustered in the last five years, financed mostly by foreign capital, and concentrated in a handful of prosperous states: this is a structural shift in who owns Indian medicine, and it has proceeded almost entirely outside public view. As private equity deepens its foothold in hospitals, laboratories, clinics, and elder care across the developing world, India now becomes the crucial test case for whether the lessons of the American experience can be anticipated and mitigated rather than repeated. The baseline evidence assembled by Reddy, Engineer, and Singh gives regulators, researchers, and citizens the map they will need if they hope to steer, rather than merely observe, the next chapter of that story.

Subject of Research: Private equity investment and ownership patterns in India's health care sector

Article Title: Mapping private equity investments in India’s health care sector: trends, ownership, and policy implications

Article References: Reddy, M., Engineer, C., & Singh, Y. (2026). Mapping private equity investments in India’s health care sector: trends, ownership, and policy implications. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15723-4

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15723-4

Keywords: private equity, India, health care, hospitals, leveraged buyouts, foreign investment, health policy, consolidation, health economics, hospital ownership, regulation, health equity